Exact Sciences' CEO Kevin Conroy weighs in on the Medicare spending talks in Washington, and discusses his company's development of non-invasive ways to detect colorectal cancer.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT